MediPharm Labs (LABS) Competitors C$0.08 0.00 (0.00%) As of 10/17/2025 03:55 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock LABS vs. CRDL, MDP, TGOD, NINE, DB, WMD, CWEB, HEXO, VIR, and ZOMShould you be buying MediPharm Labs stock or one of its competitors? The main competitors of MediPharm Labs include Cardiol Therapeutics (CRDL), Medexus Pharmaceuticals (MDP), Green Organic Dutchman (TGOD), Delta 9 Cannabis (NINE), Decibel Cannabis (DB), WeedMD (WMD), Charlotte's Web (CWEB), HEXO (HEXO), Viridium Pacific Group (VIR), and Zomedica Pharmaceuticals Corp. (ZOM.V) (ZOM). These companies are all part of the "drug manufacturers - specialty & generic" industry. MediPharm Labs vs. Its Competitors Cardiol Therapeutics Medexus Pharmaceuticals Green Organic Dutchman Delta 9 Cannabis Decibel Cannabis WeedMD Charlotte's Web HEXO Viridium Pacific Group Zomedica Pharmaceuticals Corp. (ZOM.V) MediPharm Labs (TSE:LABS) and Cardiol Therapeutics (TSE:CRDL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk. Which has preferable earnings and valuation, LABS or CRDL? MediPharm Labs has higher revenue and earnings than Cardiol Therapeutics. MediPharm Labs is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMediPharm LabsC$44.45M0.71-C$12.05M-C$0.02-3.75Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.48-3.02 Does the media favor LABS or CRDL? In the previous week, Cardiol Therapeutics had 1 more articles in the media than MediPharm Labs. MarketBeat recorded 1 mentions for Cardiol Therapeutics and 0 mentions for MediPharm Labs. MediPharm Labs' average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score. Company Overall Sentiment MediPharm Labs Neutral Cardiol Therapeutics Neutral Do insiders & institutionals have more ownership in LABS or CRDL? 0.3% of MediPharm Labs shares are held by institutional investors. Comparatively, 1.5% of Cardiol Therapeutics shares are held by institutional investors. 4.5% of MediPharm Labs shares are held by insiders. Comparatively, 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more volatility and risk, LABS or CRDL? MediPharm Labs has a beta of 0.295045, suggesting that its stock price is 70% less volatile than the S&P 500. Comparatively, Cardiol Therapeutics has a beta of 0.855752, suggesting that its stock price is 14% less volatile than the S&P 500. Is LABS or CRDL more profitable? Cardiol Therapeutics has a net margin of 0.00% compared to MediPharm Labs' net margin of -30.56%. MediPharm Labs' return on equity of -24.41% beat Cardiol Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets MediPharm Labs-30.56% -24.41% -7.17% Cardiol Therapeutics N/A -195.07%-54.15% SummaryCardiol Therapeutics beats MediPharm Labs on 6 of the 11 factors compared between the two stocks. Get MediPharm Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for LABS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LABS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LABS vs. The Competition Export to ExcelMetricMediPharm LabsDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$31.56MC$1.70BC$6.21BC$9.82BDividend YieldN/A2.95%5.70%6.50%P/E Ratio-3.75111.7385.7029.25Price / Sales0.711,634.82615.4211.33Price / Cash1.3010.3737.1083.29Price / Book0.6811.1212.235.70Net Income-C$12.05MC$20.70BC$3.33BC$301.20M7 Day PerformanceN/A-0.79%1.17%0.15%1 Month PerformanceN/A2.11%6.85%3.11%1 Year PerformanceN/A8.60%58.93%34.90% MediPharm Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LABSMediPharm LabsN/AC$0.08flatN/A+0.0%C$31.56MC$44.45M-3.75130Gap UpHigh Trading VolumeCRDLCardiol TherapeuticsN/AC$1.50flatN/A-45.3%C$125.59MN/A-3.1320News CoverageMDPMedexus Pharmaceuticals1.6169 of 5 starsC$2.92+2.8%C$4.57+56.4%+7.1%C$91.61MC$105.66M146.0098TGODGreen Organic DutchmanN/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap UpHigh Trading VolumeNINEDelta 9 CannabisN/AC$1.03+3.0%N/A+0.0%C$89.36MC$12.87M19.07940Gap UpDBDecibel CannabisN/AC$0.14flatN/A+160.0%C$80.76MC$100.50M4.6783,000Gap UpWMDWeedMDN/AC$0.28-1.8%N/A+0.0%C$67.82MC$27.53M-0.66628Gap UpCWEBCharlotte's WebN/AC$0.25-9.3%N/A+47.1%C$42.97MC$50.32M-1.75164Positive NewsGap DownHigh Trading VolumeHEXOHEXON/AN/AN/AN/AC$38.72MC$124.10M-0.26690VIRViridium Pacific GroupN/AC$0.38+5.6%N/A+0.0%C$37.52MC$1.09M-2.97580Gap UpZOMZomedica Pharmaceuticals Corp. (ZOM.V)N/AC$0.29-6.6%N/A+0.0%C$36.73MN/A-2.6150Gap Down Related Companies and Tools Related Companies Cardiol Therapeutics Competitors Medexus Pharmaceuticals Competitors Green Organic Dutchman Competitors Delta 9 Cannabis Competitors Decibel Cannabis Competitors WeedMD Competitors Charlotte's Web Competitors HEXO Competitors Viridium Pacific Group Competitors Zomedica Pharmaceuticals Corp. (ZOM.V) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:LABS) was last updated on 10/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediPharm Labs Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediPharm Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LABS Stock Alerts